-- Days : -- HRS : -- MIN : -- SEC
Register Now →
|Podcasts|November 12, 2019

Personal and Professional: One Doctor's Experience Living With and Treating Cancer

In addition to being a practicing oncologist, Mark Lewis, MD, a gastrointestinal oncologist at Intermountain Healthcare, has been living with cancer himself with a hereditary tumor syndrome that’s been passed down in his family, giving him a unique experience that has driven his approach to treating his own patients.

During this week’s podcast, we sit down with Mark Lewis, MD, a gastrointestinal oncologist at Intermountain Healthcare. In addition to being a practicing oncologist, Lewis has been living with cancer himself with a hereditary tumor syndrome that’s been passed down in his family, giving him a unique experience that has driven his approach to treating his own patients.

During the interview, Lewis discusses his personal history with cancer, how he’s seen the cancer landscape change over the last 2 decades, and his experience with treating neuroendocrine tumors.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:


Related to this article

Kenneth Komorny, PharmD, BCPS | Image: Moffitt Cancer Center
At a Stakeholder Interchange convened by The American Journal of Managed Care® in Tampa, Florida, an academic-community mix of hematologist-oncologists and pharmacists debated prior authorization, site-of-care payment disparities, and how aggressively to push bispecific antibody regimens to community practices treating patients with relapsed/refractory multiple myeloma.
Andrew D. Zelenetz, MD, PhD, is the chair of the NCCN B-cell Lymphomas panel.  | Image: LinkedIn
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.